Jushi (OTCMKTS:JUSHF) versus InMode (NASDAQ:INMD) Head-To-Head Survey

InMode (NASDAQ:INMD) and Jushi (OTCMKTS:JUSHF) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Valuation & Earnings

This table compares InMode and Jushi”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$394.82 million	2.23	$181.27 million	$2.16	6.45
Jushi	$257.52 million	0.44	-$48.78 million	($0.33)	-1.76

InMode has higher revenue and earnings than Jushi. Jushi is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares InMode and Jushi’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InMode	41.04%	14.50%	12.88%
Jushi	-25.15%	N/A	-15.07%

Institutional and Insider Ownership

68.0% of InMode shares are owned by institutional investors. Comparatively, 21.7% of Jushi shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 22.5% of Jushi shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

InMode has a beta of 2.13, suggesting that its share price is 113% more volatile than the S&P 500. Comparatively, Jushi has a beta of -1.02, suggesting that its share price is 202% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for InMode and Jushi, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1	8	1	0	2.00
Jushi	0	0	0	1	4.00

InMode presently has a consensus target price of $16.60, suggesting a potential upside of 19.08%. Given InMode’s higher probable upside, equities research analysts plainly believe InMode is more favorable than Jushi.

Summary

InMode beats Jushi on 12 of the 15 factors compared between the two stocks.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

About Jushi

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature’s Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.